Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients.
| Image |  |
|---|---|
| Description | scientific article published in January 2010 |
| Author/s |
author: Patrizia Pellegrini Tiziana Del Beato Anna Maria Berghella |
| Publication date | January 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |